Originally developed to help regulate blood sugar for individuals with type 2 diabetes, these medications have gained recognition for their ability to support weight loss and appetite control
These medications carry a boxed warning regarding thyroid C-cell tumor risk observed in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
This fatigue is not just ordinary tiredness
Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice
Compounded Semaglutide Tablets A once-daily oral tablet taken before food, beverages, and other oral medications
Phase 3 clinical trials are still underway, coming to a close in May 2026